BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20206155)

  • 1. Multicenter evaluation of the first automated Elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia.
    Schiettecatte J; Russcher H; Anckaert E; Mees M; Leeser B; Tirelli AS; Fiedler GM; Luthe H; Denk B; Smitz J
    Clin Biochem; 2010 Jun; 43(9):768-70. PubMed ID: 20206155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical evaluation of the novel soluble fms-like tyrosine kinase 1 and placental growth factor assays for the diagnosis of preeclampsia.
    van Helden J; Weiskirchen R
    Clin Biochem; 2015 Nov; 48(16-17):1113-9. PubMed ID: 26129879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.
    Buhimschi CS; Norwitz ER; Funai E; Richman S; Guller S; Lockwood CJ; Buhimschi IA
    Am J Obstet Gynecol; 2005 Mar; 192(3):734-41. PubMed ID: 15746665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia.
    Ohkuchi A; Hirashima C; Suzuki H; Takahashi K; Yoshida M; Matsubara S; Suzuki M
    Hypertens Res; 2010 May; 33(5):422-7. PubMed ID: 20150910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the diagnostic utility of the sFlt-1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome.
    Stepan H; Hund M; Gencay M; Denk B; Dinkel C; Kaminski WE; Wieloch P; Semus B; Meloth T; Dröge LA; Verlohren S
    Hypertens Pregnancy; 2016 Aug; 35(3):295-305. PubMed ID: 27028698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
    Park CW; Park JS; Shim SS; Jun JK; Yoon BH; Romero R
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elecsys® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable?
    Stepan H; Hund M; Dilba P; Sillman J; Schlembach D
    Clin Chem Lab Med; 2019 Aug; 57(9):1339-1348. PubMed ID: 31323000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients.
    Verlohren S; Herraiz I; Lapaire O; Schlembach D; Moertl M; Zeisler H; Calda P; Holzgreve W; Galindo A; Engels T; Denk B; Stepan H
    Am J Obstet Gynecol; 2012 Jan; 206(1):58.e1-8. PubMed ID: 22000672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of Kryptor and Elecsys® immunoassay sFlt-1/PlGF ratio on early diagnosis of preeclampsia and fetal growth restriction: A case-control study.
    Simón E; Herraiz I; Villalaín C; Gómez-Arriaga PI; Quezada MS; López-Jiménez EA; Galindo A
    Pregnancy Hypertens; 2020 Apr; 20():44-49. PubMed ID: 32172169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of repeated measurements of the sFlt-1/PlGF ratio for the prediction of preeclampsia and intrauterine growth restriction.
    Schoofs K; Grittner U; Engels T; Pape J; Denk B; Henrich W; Verlohren S
    J Perinat Med; 2014 Jan; 42(1):61-8. PubMed ID: 23929878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia.
    Verlohren S; Galindo A; Schlembach D; Zeisler H; Herraiz I; Moertl MG; Pape J; Dudenhausen JW; Denk B; Stepan H
    Am J Obstet Gynecol; 2010 Feb; 202(2):161.e1-161.e11. PubMed ID: 19850276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influences on Placental Growth Factor (PlGF) and Soluble fms-like Tyrosine Kinase-1 (sFlt-1) Concentration Levels at the Time of First Trimester Screening].
    von See J; Limperger V; Pecks U; Eckmann-Scholz C
    Z Geburtshilfe Neonatol; 2016 Aug; 220(4):166-72. PubMed ID: 27135751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of preeclampsia with soluble Fms-like tyrosine kinase 1/placental growth factor ratio: an inter-assay comparison.
    Andersen LB; Frederiksen-Møller B; Work Havelund K; Dechend R; Jørgensen JS; Jensen BL; Nielsen J; Lykkedegn S; Barington T; Christesen HT
    J Am Soc Hypertens; 2015 Feb; 9(2):86-96. PubMed ID: 25600419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of preeclampsia and fetal growth restriction with the sFlt-1/PlGF ratio: Diagnostic accuracy of the automated immunoassay Kryptor®.
    Dröge LA; Höller A; Ehrlich L; Verlohren S; Henrich W; Perschel FH
    Pregnancy Hypertens; 2017 Apr; 8():31-36. PubMed ID: 28501276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
    Rajakumar A; Michael HM; Rajakumar PA; Shibata E; Hubel CA; Karumanchi SA; Thadhani R; Wolf M; Harger G; Markovic N
    Placenta; 2005 Aug; 26(7):563-73. PubMed ID: 15993706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia.
    Verlohren S; Herraiz I; Lapaire O; Schlembach D; Zeisler H; Calda P; Sabria J; Markfeld-Erol F; Galindo A; Schoofs K; Denk B; Stepan H
    Hypertension; 2014 Feb; 63(2):346-52. PubMed ID: 24166751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predictive value of soluble vascular endothelial growth factor receptor 1 for preeclampsia in second-trimester].
    Chen Q; Zhao Y; Zou L; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):161-4. PubMed ID: 17537299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inter-manufacturer comparison of automated immunoassays for the measurement of soluble FMS-like tyrosine kinase-1 and placental growth factor.
    Cheng YKY; Poon LCY; Shennan A; Leung TY; Sahota DS
    Pregnancy Hypertens; 2019 Jul; 17():165-171. PubMed ID: 31487636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predictive value of serum soluble fms-like tyrosine kinase 1 concentration in preeclampsia at second trimester].
    Ye YH; Liu L; Zhan Y; Peng W
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):433-5. PubMed ID: 17083803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010.
    Hermsen D; Franzson L; Hoffmann JP; Isaksson A; Kaufman JM; Leary E; Müller C; Nakatsuka K; Nishizawa Y; Reinauer H; Riesen W; Roth HJ; Steinmüller T; Troch T; Bergmann P
    Clin Lab; 2002; 48(3-4):131-41. PubMed ID: 11934215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.